These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 3323414)
1. Differentiation of a human monocytic cell line associated with increased production of Rift Valley fever virus by infected cells. Lewis RM; Cosgriff TM; Peters CJ; Morrill JC J Med Virol; 1987 Nov; 23(3):207-15. PubMed ID: 3323414 [TBL] [Abstract][Full Text] [Related]
3. Enzyme-linked immunosorbent assay for detection of Rift Valley fever virus antigen in mosquitoes. Niklasson BS; Gargan TP Am J Trop Med Hyg; 1985 Mar; 34(2):400-5. PubMed ID: 3985279 [TBL] [Abstract][Full Text] [Related]
4. Comparative pathogenicity and antigenic cross-reactivity of Rift Valley fever and other African phleboviruses in sheep. Swanepoel R; Struthers JK; Erasmus MJ; Shepherd SP; McGillivray GM; Shepherd AJ; Hummitzsch DE; Erasmus BJ; Barnard BJ J Hyg (Lond); 1986 Oct; 97(2):331-46. PubMed ID: 3537119 [TBL] [Abstract][Full Text] [Related]
5. The effect of laboratory colonization on the vector-pathogen interactions of Egyptian Culex pipiens and Rift Valley fever virus. Gargan TP; Bailey CL; Higbee GA; Gad A; El Said S Am J Trop Med Hyg; 1983 Sep; 32(5):1154-63. PubMed ID: 6625070 [TBL] [Abstract][Full Text] [Related]
6. Transmission of Rift Valley fever virus by the sand fly, Phlebotomus duboscqi (Diptera: Psychodidae). Turell MJ; Perkins PV Am J Trop Med Hyg; 1990 Feb; 42(2):185-8. PubMed ID: 2316789 [TBL] [Abstract][Full Text] [Related]
7. Reduced Rift Valley fever virus infection rates in mosquitoes associated with pledget feedings. Turell MJ Am J Trop Med Hyg; 1988 Dec; 39(6):597-602. PubMed ID: 3207178 [TBL] [Abstract][Full Text] [Related]
8. Immunoelectron microscopy of Rift Valley fever viral morphogenesis in primary rat hepatocytes. Anderson GW; Smith JF Virology; 1987 Nov; 161(1):91-100. PubMed ID: 3499704 [TBL] [Abstract][Full Text] [Related]
9. Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate. Ikegami T Expert Rev Vaccines; 2017 Jun; 16(6):601-611. PubMed ID: 28425834 [TBL] [Abstract][Full Text] [Related]
10. Replication and dissemination of Rift Valley fever virus in Culex pipiens. Turell MJ; Gargan TP; Bailey CL Am J Trop Med Hyg; 1984 Jan; 33(1):176-81. PubMed ID: 6696176 [TBL] [Abstract][Full Text] [Related]
11. Reversed passive hemagglutination and inhibition with Rift Valley fever and Crimean-Congo hemorrhagic fever viruses. Swanepoel R; Struthers JK; McGillivray GM Am J Trop Med Hyg; 1983 May; 32(3):610-7. PubMed ID: 6407347 [TBL] [Abstract][Full Text] [Related]
12. Production of small ruminant morbillivirus, rift valley fever virus and lumpy skin disease virus in CelCradle™ -500A bioreactors. Rhazi H; Safini N; Mikou K; Alhyane M; Tadlaoui KO; Lin X; Venkatesan NP; Elharrak M BMC Vet Res; 2021 Feb; 17(1):93. PubMed ID: 33639955 [TBL] [Abstract][Full Text] [Related]
13. Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments. Ikegami T; Hill TE; Smith JK; Zhang L; Juelich TL; Gong B; Slack OA; Ly HJ; Lokugamage N; Freiberg AN J Virol; 2015 Jul; 89(14):7262-76. PubMed ID: 25948740 [TBL] [Abstract][Full Text] [Related]
14. [Rift Valley fever]. Pépin M; Med Mal Infect; 2011 Jun; 41(6):322-9. PubMed ID: 21295425 [TBL] [Abstract][Full Text] [Related]
15. Rift Valley fever vaccine--antibody and immune response in cattle to a live and an inactivated vaccine. Barnard BJ J S Afr Vet Assoc; 1979 Sep; 50(3):155-7. PubMed ID: 551199 [TBL] [Abstract][Full Text] [Related]
16. Morphology and development of Rift Valley fever virus in Vero cell cultures. Ellis DS; Shirodaria PV; Fleming E; Simpson DI J Med Virol; 1988 Feb; 24(2):161-74. PubMed ID: 3280732 [TBL] [Abstract][Full Text] [Related]
17. Experimental Rift Valley fever in rhesus macaques. Peters CJ; Jones D; Trotter R; Donaldson J; White J; Stephen E; Slone TW Arch Virol; 1988; 99(1-2):31-44. PubMed ID: 3355374 [TBL] [Abstract][Full Text] [Related]
18. [Rift Valley Fever and phleboviroses in the Central African Republic]. Meunier DM; Madelon MC; Lesbordes JL; Georges AJ Bull Soc Pathol Exot Filiales; 1988; 81(1):49-57. PubMed ID: 3042177 [TBL] [Abstract][Full Text] [Related]
19. The L, M, and S Segments of Rift Valley Fever Virus MP-12 Vaccine Independently Contribute to a Temperature-Sensitive Phenotype. Nishiyama S; Lokugamage N; Ikegami T J Virol; 2016 Jan; 90(7):3735-44. PubMed ID: 26819307 [TBL] [Abstract][Full Text] [Related]
20. Novel suspension cell-based vaccine production systems for Rift Valley fever virus-like particles. Mandell RB; Koukuntla R; Mogler LJ; Carzoli AK; Holbrook MR; Martin BK; Vahanian N; Link CJ; Flick R J Virol Methods; 2010 Nov; 169(2):259-68. PubMed ID: 20655330 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]